comparemela.com

Latest Breaking News On - Daniel stauder - Page 1 : comparemela.com

Avanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Call Transcript

Operator: Good morning ladies and gentlemen and welcome to the Avanos First Quarter 2024 Earnings Conference. At this time, all lines are in a listen-only mode.

United-states
Toronto
Ontario
Canada
America
Daniel-stauder
Scott-galovan
Michael-greiner
Kristen-stewart
Digestive-health
Your-digestive-health
Avanos-medical-inc

An atrial fibrillation device maker has 70% upside, JMP Securities says

Analyst Daniel Stauder initiated coverage of the stock with an outperform rating and $60 price target, implying shares could soar by almost 70%.

Daniel-stauder
Open-ablation
Michael-bloom
Breaking-news-markets
Stock-markets
Investment-strategy
Markets
Atricure-inc
Business-news

Potential Turnaround Ahead for Nevro: Q2 Earnings, Guidance Lag Wall Street Estimates - Nevro (NYSE:NVRO)

Pain management company Nevro Corp (NASDAQ: NVRO) reported Q2 FY23 revenue of $108.8 million, up 4% Y/Y, missing the management guidance of $110 million-$112 million and 

Brandon-vazquez
Daniel-stauder
William-blair
Nevro-corp
David-turkaly
Justin-lin
Diabetic-neuropathy
Market-outperform
Market-perform

Neuronetics, Inc. (NASDAQ:STIM) Q1 2023 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to the Neuronetics First Quarter 2023 Financial and Operating Results. [Operator Instructions] As a reminder, today s program is being recorded.

Mississippi
United-states
Tennessee
Greenbrook
North-carolina
Nashville
Adam-maeder
Daniel-stauder
Margaret-kaczor
William-blair
Mark-klausner
William-plovanic

vimarsana © 2020. All Rights Reserved.